Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...
Amgen Inc . (NASDAQ:AMGN), a leading biopharmaceutical company with a market capitalization of $149 billion, is navigating a ...
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
The focus on how BMI should be used may have overshadowed an equally, if not more important, matter proposed in a new report.
However, a recent study from Johns Hopkins University offers new hope. Researchers found that an experimental drug, ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback